LTX2A_NEOCU
ID LTX2A_NEOCU Reviewed; 25 AA.
AC P0DV16;
DT 23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT 23-FEB-2022, sequence version 1.
DT 03-AUG-2022, entry version 2.
DE RecName: Full=M-poneritoxin-Nc2a {ECO:0000303|PubMed:34302796};
DE Short=M-PONTX-Nc2a {ECO:0000303|PubMed:34302796};
DE AltName: Full=Poneratoxin {ECO:0000305};
DE AltName: Full=Ponericin Nc2a {ECO:0000303|PubMed:34302796};
OS Neoponera commutata (Large hunting ant) (Pachycondyla commutata).
OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Formicoidea;
OC Formicidae; Ponerinae; Ponerini; Pachycondyla.
OX NCBI_TaxID=613619;
RN [1]
RP PROTEIN SEQUENCE, SUBCELLULAR LOCATION, MASS SPECTROMETRY, SYNTHESIS, TOXIC
RP DOSE, AND BIOASSAY.
RC TISSUE=Venom;
RX PubMed=34302796; DOI=10.1016/j.bcp.2021.114693;
RA Nixon S.A., Robinson S.D., Agwa A.J., Walker A.A., Choudhary S.,
RA Touchard A., Undheim E.A.B., Robertson A., Vetter I., Schroeder C.I.,
RA Kotze A.C., Herzig V., King G.F.;
RT "Multipurpose peptides: the venoms of Amazonian stinging ants contain
RT anthelmintic ponericins with diverse predatory and defensive activities.";
RL Biochem. Pharmacol. 192:114693-114693(2021).
CC -!- FUNCTION: Membrane-perturbating peptide with multiple activities
CC (PubMed:34302796). It is insecticidal, since it induces reversible
CC paralysis in insects (L.cuprina) after 1 hour, but fails to kill them
CC (PubMed:34302796). It shows moderate antibacterial activity against
CC some Gram-positive and Gram-negative bacteria (PubMed:34302796). It is
CC also antiparasitic, since it moderately inhibits the larval development
CC of the major pathogenic nematode of ruminants (H.contortus, IC(50)=23.2
CC uM), but fails to reduce the motility of adult males of the other
CC nematode B.malayi (PubMed:34302796). It also shows moderate cytotoxic
CC activity against HEK293 cells (EC(50)=48-57 uM) but does not induce
CC hemolysis in human erythrocytes (PubMed:34302796). It also causes a
CC moderate increase in intracellular calcium concentration on neuronal
CC and epithelial cell lines, which supports a non-specific membrane
CC perturbation mechanism of action (PubMed:34302796).
CC {ECO:0000269|PubMed:34302796}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:34302796}. Target
CC cell membrane {ECO:0000305|PubMed:34302796}. Note=Adopts an alpha-
CC helical conformation in membrane-mimetic environments.
CC {ECO:0000305|PubMed:34302796}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC {ECO:0000305|PubMed:34302796}.
CC -!- MASS SPECTROMETRY: Mass=2725.2; Method=MALDI; Note=Monoisotopic mass.;
CC Evidence={ECO:0000269|PubMed:34302796};
CC -!- TOXIC DOSE: PD(50) is 38.1 nmol/g 1 hour after injection into
CC L.cuprina. LD(50) is >100 nmol/g 24 hours after injection into
CC L.cuprina. {ECO:0000269|PubMed:34302796}.
CC -!- SIMILARITY: Belongs to the ponericin-L family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
PE 1: Evidence at protein level;
KW Antibiotic; Antimicrobial; Direct protein sequencing; Membrane; Secreted;
KW Target cell membrane; Target membrane; Toxin.
FT PEPTIDE 1..25
FT /note="M-poneritoxin-Nc2a"
FT /evidence="ECO:0000269|PubMed:34302796"
FT /id="PRO_0000454517"
SQ SEQUENCE 25 AA; 2727 MW; A8CA85542FB3EC8F CRC64;
FVKELWDKVK KMGSAAWSAA KGAFA